帕金森病模型大鼠脑组织SPTLC2的表达研究

摘要
图/表
参考文献(16)
相关文章 (15)

全文: PDF (704 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探究丝氨酸棕榈酰转移酶长链亚基2（SPTLC2）在帕金森病大鼠脑组织中的表达。方法采用注射6-羟基多巴胺制备帕金森病大鼠模型，将模型组分为三组：模型组（2周）、模型组（4周）、模型组（8周），同时设置正常组，采用异常不自主动作（AIM）评分法评定各组大鼠行为，同时记录旋转持续时间、启动时间、剂峰旋转圈数。HE染色法观察大鼠脑组织变化，免疫组化法检测大鼠脑组织中α突触核蛋白的表达，逆转录聚合酶链反应（RT-PCR）法测定大鼠脑组织中SPTLC2 mRNA表达，Western blot检测大鼠脑组织中SPTLC2蛋白表达。结果模型组大鼠AIM评分、旋转持续时间、启动时间、剂峰旋转圈数均高于正常组，随着时间的延长，AIM评分、旋转启动时间、剂峰旋转圈数逐渐升高，旋转启动时间逐渐降低，差异有统计学意义（P ＜ 0.05）。免疫组化染色显示，正常组α突触核蛋白阳性细胞数量较少，模型组阳性细胞数量明显增多，且随着时间的延长，阳性细胞数量逐渐升高。与正常组、模型组（2周）相比，模型组（4周）、模型组（8周）SPTLC2基因、蛋白表达量均升高；与模型组（4周）相比，模型组（8周）SPTLC2基因、蛋白表达量升高，差异有统计学意义（P ＜ 0.05）。结论 SPTLC2可能参与帕金森病疾病的发生，通过上调SPTLC2基因、蛋白水平的表达来实现。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	何晓燕焦燕李红燕

关键词 ：帕金森病, 丝氨酸棕榈酰转移酶长链亚基2, 脑组织, 模型

Abstract：Objective To explore the expression of serine palmitate transferase long chain subunit 2 (SPTLC2) in brain tissue in the rat model of Parkinson disease. Methods Parkinson rat model was prepared by injecting 6-hydroxy dopamine, and the rats were divided into three groups, 2-week model group, 4-week model group, 8-week model group, and normal group. Behaviors of rats in each group were assessed by using abnormal involuntary movement (AIM) scoring method. Rotation duration, starting time, the cycle number of agent peak were recorded meanwhile. HE staining method was used to observe the changes of brain tissue in rats, and the expression of α synuclein in rat brain tissue was detected by immunohistochemistry, and SPTLC2 and mRNA expression in brain tissue of rats was detected by using RT-PCR, and SPTLC2 protein expression in rat brain tissue was detected by Western blot. Results AIM score, rotation duration, starting time, agent peak rotation number in model group was higher than those in the normal group, and with the extension of time, AIM score, rotating start time, agent peak rotation number gradually increased, while the rotation starting time gradually decreased, with statistically significant differences (P ＜ 0.05). Immunohistochemical staining showed that the number of positive cells in the normal group was less than that in the normal group, and the number of positive cells in the model group increased significantly. The number of positive cells increased gradually with the extension of time. Compared with those in the normal group and 2-week model group, SPTLC2 gene and protein expression in 4-week and 8-week model group increased, and compared with 4-week model group, SPTLC2 gene and protein expression in 8-week model group increased, with statistically significant differences (P ＜ 0.05). Conclusion SPTLC2 may be involved in the pathogenesis of Parkinson disease, via up-regulating SPTLC2 gene and protein expression.

Key words： Parkinson disease Serine palmitate transferase long chain subunit 2 Brain tissue Model

基金资助:新疆维吾尔自治区自然科学基金资助项目医学联合基金项目（2015211C210）。

通讯作者: 李红燕（1969.10-），女，博士，主任医师；研究方向：帕金森病。

作者简介: 何晓燕（1981.6-），女，硕士；研究方向：神经感染与免疫。

引用本文:

何晓燕焦燕李红燕. 帕金森病模型大鼠脑组织SPTLC2的表达研究[J]. 中国医药导报, 2018, 15(13): 21-24,30.
HE Xiaoyan JIAO Yan LI Hongyan. Study on SPTLC2 expression level in brain tissue in the rat model of Parkinson disease. 中国医药导报, 2018, 15(13): 21-24,30.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2018/V15/I13/21

[1] 张雪，张雯，杜立达，等.抗帕金森病病药物及其作用靶点研究进展[J].国际药学研究杂志，2016，43（1）：87-96.
[2] Nicholson.常染色体显性遗传性感觉神经病变伴慢性咳嗽和胃食管反流：2个染色体3p22-p24相关家族的临床特征[J].世界核心医学期刊文摘：神经病学分册，2006， 24（6）：54-54.
[3] 陈旭，耿翔.帕金森病病发病机制新进展[J].中华老年心脑血管病杂志，2014，16（9）：897-898.
[4] Early M，Wink L，Erickson C，et al. Abnormal Involuntary Movement Scale [J]. Schizophr Res. 2005，77（2/3）：119-128.
[5] 李晓霞.锰与帕金森病病发病机制的相关研究[J].成都医学院学报，2013，8（6）：720-723.
[6] Drake JD，Kibuuka LN，Dimitrov KD，et al. Abnormal involuntary movement（AIM）expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation（priming）in 6-hydroxydopamine lesioned rats [J]. Pharmacol Biochem Behav，2013， 105（12）：26-33.
[7] 孙涛.帕金森病病实验动物模型的研究进展[J].中国新药杂志，2014，23（18）：2155-2160.
[8] 魏翔，刘晓莉.帕金森病病大鼠模型运动行为测评方法的研究进展[J].中国实验动物学报，2015，23（2）：209-215.
[9] Ho SC，Hsu CC，Pawlak CR，et al. Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model [J]. Behav Brain Res，2014，15（268）：177-184. Doi：10.1016/j.bbr.2014.04.022.
[10] Tran HT，Chung CH，Iba M，et al. A-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration [J]. Cell Rep，2014，7（6）：2054-2065.
[11] Dettmer U，Newman AJ，Luth ES，et al. In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells [J]. J Biol Chem，2013，288（9）：6371-6385.
[12] Wang X，Chen Q，Xing D. Focal adhesion kinase activates NF-κB via the ERK1/2 and p38MAPK Pathways in amyloid-β25-35-induced apoptosis in PC12 cells [J]. J Alzheimers Dis，2012，32（1）：77-81.
[13] 楼彩霞.髓系细胞特异性Sptlc2基因缺失对小鼠动脉粥样硬化病灶的影响[D].北京：中央民族大学，2013.
[14] Suriyanarayanan S，Auranen M，Toppila J，et al. The Variant p.（Arg183Trp）in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy [J]. Neuromolecular Med，2016， 18（1）：81-85.
[15] Lee SY，Kim JR，Hu Y，et al. Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction [J]. J Bio Chem，2012，287（22）：18429-18433.
[16] 刘青.SPT抑制剂多球壳菌素对油酸诱导的HSC凋亡及自噬的影响[D].衡阳：南华大学，2016.